Literature DB >> 31881617

Botulinum Toxin A Salvage of Ischemic Hand Trauma.

Avra S Laarakker1, Gregory Borah.   

Abstract

Posttraumatic hand injuries from crush injury, infusion, or iatrogenic vascular cannulation can cause ischemic finger damage that can progress to necrosis and digital amputation. Botulinum toxin type A (Botox) improves blood flow in chronic vasospastic disorders of the hand. Botox's efficacy in salvaging ischemic loss in digits in acute traumatic and iatrogenic injury has not been previously reported. From February of 2015 to December of 2016, 11 patients at a Level I trauma center (West Virginia University) presented to the hand surgery service with early ischemic injury and vascular compromise to hand and fingers as a result of crush, direct drug injection, or proximal arterial injury from drug injection or catheterization. Before 2015, all patients with vascular compromise were treated with standard protocol. After January of 2016, patients were treated with additional injection of 80 to 100 U of Botox into the palm and wrist. Before administration of Botox, six patients with vascular compromise of one or more fingers were treated with a conservative protocol and 83 percent had amputation of necrotic digits. After January of 2016, five patients with ischemia were treated with Botox into the palm and proximal arteries. All Botox-treated digits were preserved (100 percent salvage). Pain scores were lower in Botox-treated fingers. We conclude that (1) in the acute traumatic vascular hand injury, early Botox injection markedly increases digital salvage; (2) direct nerve effects after Botox injections improve postinjury pain scores; and (3) early use of Botox in finger injuries is our standard approach to impending ischemia in the hand.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31881617     DOI: 10.1097/PRS.0000000000006379

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Botulinum Toxin A for the Treatment of Sympathomimetic Pressor-Induced Digital Hand Ischemia in the Critically Ill Intensive Care Unit Patient.

Authors:  Henning De May; Avra S Laarakker; Gregory Borah
Journal:  Hand (N Y)       Date:  2022-02-21

Review 2.  Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury.

Authors:  Michael Adler; Sabine Pellett; Shashi K Sharma; Frank J Lebeda; Zygmunt F Dembek; Mark A Mahan
Journal:  Microorganisms       Date:  2022-04-24

3.  Safety and efficacy of botulinum toxin type A in preventing and treating scars in animal models: A systematic review and meta-analysis.

Authors:  Lingfeng Pan; Haiyan Qin; Caihong Li; Liehao Yang; Mingxi Li; Jiao Kong; Guang Zhang; Lianbo Zhang
Journal:  Int Wound J       Date:  2021-08-17       Impact factor: 3.099

4.  Botulinum Toxin in the Treatment of Vasopressor-associated Symmetric Peripheral Gangrene.

Authors:  Jenna R Stoehr; Aaron M Kearney; Jonathan P Massie; Jason H Ko; Gregory A Dumanian
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-05-21

Review 5.  Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article.

Authors:  Waranaree Winayanuwattikun; Vasanop Vachiramon
Journal:  Toxins (Basel)       Date:  2022-06-14       Impact factor: 5.075

6.  Acral Necrosis in a COVID-19-Infected Man Treated with Botulinum Toxin Type A.

Authors:  Mette Soelberg Schjødt; Rikke Bech; Anne Braae Olesen
Journal:  Case Rep Dermatol       Date:  2021-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.